Hongmei Wang — Guangzhou University of Chinese Medicine

Area of research

Environmental Engineering · Oncology

Research interest

Research focused on Hepatocellular carcinoma and Leukopenia, with related work in Stem cell, Oncogene, Thiopurine methyltransferase. Notable publications include 'Stem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited', 'Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial', and 'The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma'.

Recent publications

Stem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited

Stem Cell Reports 2025cited by 20position: middledoi

Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial

Signal Transduction and Targeted Therapy 2024cited by 3position: middledoi

The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma

Molecular Medicine Reports 2024cited by 1position: middledoi

13 Individualized use of 6-mercaptopurine in the maintenance treatment of Chinese children with acute lymphoblastic leukemia: a multicenter randomized controlled trial

2024cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Environmental Engineering · Oncology →